As shown in Figure 5A–C, expression levels of genes and proteins typical of AD, such as APP, BACE1, Aβ, and p-tau, were elevated in both phases of the exposure cycle, especially in the high-dose group (Figure 5A–C; p < 0.01). The gene discussed is MAPT; the disease is Alzheimer disease.